Published price vs quote-only
Wellorithm vs Start Willow: Which One Publishes Its Price? (2026)
Wellorithm or Start Willow? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.3 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Wellorithm and Start Willow usually comes down to one difference that neither homepage puts in its headline.
Start Willow publishes what it charges — From $249 the first month, then $299/mo. Wellorithm does not: pricing is not published; you receive a quote only after completing the intake quiz. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Easier to price in advance
- Start Willow — From $249 the first month, then $299/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Start Willow — Direct-pay model that bypasses insurance pre-authorization.
- Tirzepatide access
- Start Willow — The only one of the two that publishes a dual GIP/GLP-1 option.
- Easiest to pay for
- Wellorithm — Neither publishes financing; both expect the full amount monthly.
Wellorithm vs Start Willow at a glance
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| Wellorithm | Start Willow | |
|---|---|---|
| Advertised price | Priced after the eligibility quiz | From $249 the first month, then $299/mo |
| Rate after promotions | not published before intake | $299/mo |
| Pricing structure | Quoted only after intake | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Tirzepatide | Not published | Available |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Medication shipped to your home | Delivery guaranteed in 3 days or less |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 3,240 | 6,385 |
| eRxDoctor score | 7.5/10 | 7.3/10 |
What Wellorithm and Start Willow actually cost over a year
The cheapest first month and the cheapest year are frequently different providers. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Wellorithm | Start Willow | |
|---|---|---|
| First month | Not published | $249 |
| Months 2 onward | Not published | $299/mo |
| 6-month total | Not computable | $1,744 |
| 12-month total | Not computable | $3,538 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
Pricing you can check, and pricing you cannot
With Start Willow the arithmetic is available in advance — From $249 the first month, then $299/mo, on promotional first month, then standard rate terms — so it can be compared against anything else on the market.
Wellorithm runs the other way around — pricing is not published; you receive a quote only after completing the intake quiz. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
The workaround is straightforward: complete Wellorithm's assessment, get the quote, and then price it against Start Willow's published $299/mo before agreeing to anything.
Wellorithm in detail
Wellorithm positions itself on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin. Take the 2-Minute Quiz to Check Your Eligibility
Practically: 2-minute eligibility quiz, medication shipped to your home, and a pricing model that is quoted only after intake.
Ongoing care is virtual consultations with licensed clinicians, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- Both compounded semaglutide and tirzepatide available
- Fully virtual consultations with medication shipped to your home
- No insurance pre-authorization required
Wellorithm cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Pricing is not published, you only get a quote after completing the intake quiz
- Smaller, less-established platform with limited public reviews
Where it gives ground to Start Willow: a smaller platform with no published price and limited public review volume.
Inside the Start Willow program
From $249 per Month Against Wellorithm, that puts it in the position of the harder of the two to price in advance.
From signup to first shipment: fully online, no in-person visits, then delivery guaranteed in 3 days or less. Billing follows a promotional first month, then standard rate structure.
Support: direct-pay model that bypasses insurance pre-authorization. The medications on offer are compounded semaglutide and compounded tirzepatide.
Start Willow pros
- Fully online, no in-person visits or insurance forms
- Medications comparable to Ozempic and tirzepatide
- No insurance needed and no membership fees
- Direct-pay model bypasses insurance pre-authorization entirely
Start Willow cons
- Price rises from $249 first month to $299/month ongoing
- Ongoing $299/month is among the higher rates on this list
- Compounded medication only, no branded Ozempic or Wegovy
Set beside Wellorithm, the thing to weigh: at $299 ongoing it is among the most expensive compounded programs here.
Who each program is actually built for
Choose Wellorithm if:
- delivery works the way you want it to: medication shipped to your home
- you want to start on their timeline: 2-minute eligibility quiz
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- the feature you would actually use: licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin
Choose Start Willow if:
- delivery works the way you want it to: delivery guaranteed in 3 days or less
- you want to start on their timeline: fully online, no in-person visits
- you want the full price in front of you before completing an intake
- you want tirzepatide available without changing provider later
Honest trade-offs
On price. Only Start Willow publishes a rate you can plan against (From $249 the first month, then $299/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On clinical contact. The support models differ — virtual consultations with licensed clinicians against direct-pay model that bypasses insurance pre-authorization — and that difference is felt in week two, not week one.
On medication. Wellorithm covers compounded semaglutide and compounded tirzepatide; Start Willow covers compounded semaglutide and compounded tirzepatide. Only Start Willow publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Wellorithm advertises 2-minute eligibility quiz and medication shipped to your home; Start Willow advertises fully online, no in-person visits and delivery guaranteed in 3 days or less. Coverage differs too — all 50 states against not published — which decides the question before price does if you are in a restricted state.
The clinical evidence, separated from the marketing
Neither Wellorithm nor Start Willow manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
In SURMOUNT-1, tirzepatide reached a mean body-weight reduction of about 21% at the 15 mg dose over 72 weeks, per NEJM, SURMOUNT-1.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Wellorithm vs Start Willow: common questions
What happens when Start Willow's promotional price ends?
The rate moves to $299/mo, a 20% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
How fast can I start with Wellorithm compared with Start Willow?
Wellorithm advertises 2-minute eligibility quiz, with medication shipped to your home. Start Willow advertises fully online, no in-person visits, with delivery guaranteed in 3 days or less. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Wellorithm or Start Willow take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Wellorithm or Start Willow?
Start Willow, with 6,385 against 3,240. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Can I switch from Wellorithm to Start Willow later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge.
Is Wellorithm or Start Willow better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Wellorithm has the stronger case; after month three, cost should take over.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin; Start Willow leads on a delivery guarantee of three days or less and no membership stacked on the medication price.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Refills vs WellorithmPublished price vs quote-only
- Embody vs WellorithmPublished price vs quote-only
- Start Willow vs Elevate HealthBudget vs premium
- Start Willow vs TMatesLocked price vs escalating price
- Shed vs Enhance MDPublished price vs quote-only
- Shed vs altRxPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellorithm or Start Willow, and does not sell treatment. Read our ranking methodology.